National Institute of Neurological Disorders and Stroke; Notice of Meeting, 36563-36564 [2012-14932]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices
physical and mental health of the
American people.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 4, 2012.
Yvette Roubideaux,
Director, Indian Health Service.
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
[FR Doc. 2012–14887 Filed 6–18–12; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service; Reimbursement
Rates for Calendar Year 2012
Correction
AGENCY:
ACTION:
Indian Health Service, HHS.
Notice; correction.
The Indian Health Service
published a document in the Federal
Register on June 6, 2012, concerning
rates for inpatient and outpatient
medical care provided by Indian Health
Service facilities for Calendar Year 2012
for Medicare and Medicaid beneficiaries
of other Federal Programs. The
document contained five incorrect rates.
SUMMARY:
Mr.
Carl Harper, Director, Office of Resource
Access and Partnerships, Indian Health
Service, 801 Thompson Avenue, Suite
360, Rockville, MD 20852, Telephone
301–443–1553. (This is not a toll-free
number.)
FOR FURTHER INFORMATION CONTACT:
Corrections
In the Federal Register of June 6,
2012, in FR Doc. 2012–13627, on page
33470, in the second column, under the
heading ‘‘Inpatient Hospital Per Diem
Rate (Excludes Physician/Practitioner
Services)’’ ‘‘Lower 48 States: $2,169.
Alaska: $2,350.’’ should read ‘‘Lower 48
States: $2,165. Alaska: $2,347.’’ Under
the heading, ‘‘Outpatient Per Visit Rate
(Excluding Medicare) ‘‘Lower 48 States:
$317.’’ should read ‘‘Lower 48 States:
$316.’’ Under the heading, ‘‘Medicare
Part B Inpatient Ancillary Per Diem
Rate’’ ‘‘Lower 48 States: $477. Alaska:
$811.’’ should read ‘‘Lower 48 States:
$476. Alaska: $810.’’
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; R–13 Conference Grants.
Date: July 10–11, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An12F, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Lisa A. Newman, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3As19K, Bethesda, MD
20892, 301–435–0965,
newmanla2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: June 12, 2012.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Review Committee.
Date: July 11, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sujata Vijh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, ARRB/DEA/NIAID/NIH, 6700B
Rockledge Drive, MSC 7616, Room 3118,
Bethesda, MD 20892–7616, 301–594–0985,
vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–14930 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
National Institute of Allergy And
Infectious Diseases; Notice of Closed
Meeting
[FR Doc. 2012–14896 Filed 6–18–12; 8:45 am]
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a conference call of the
Interagency Pain Research Coordinating
Committee (IPRCC).
The IPRCC full Committee will be
having a conference call on Thursday,
June 28, 2012. This teleconference will
be focused predominantly on a
discussion of the proposed list of pain
research topics that will be used for the
portfolio analysis of Federally-funded
pain research. This conference call will
be accessible to the public through a
call-in number and access code.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
Dated: June 8, 2012.
Randy Grinnell,
Deputy Director, Indian Health Service.
srobinson on DSK4SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidentialtrade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
36563
Name of Committee: Interagency Pain
Research Coordinating Committee (IPRCC).
[FR Doc. 2012–14927 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4165–16–P
VerDate Mar<15>2010
16:39 Jun 18, 2012
Jkt 226001
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
E:\FR\FM\19JNN1.SGM
19JNN1
36564
Federal Register / Vol. 77, No. 118 / Tuesday, June 19, 2012 / Notices
Type of meeting: Open Meeting.
Date: June 28, 2012.
Time: 1:00 p.m. to 2:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: To discuss the proposed list of
pain research topics that will be used for the
portfolio analysis of Federally-funded pain
research.
Place: No in-person meeting; conference
call only.
Conference Call: Dial: 800–369–2109,
Access Code: 5033271.
Cost: The conference call is free and open
to the public.
Contact Person: Dr. Paul Scott, Director,
Office of Science Policy and Planning,
National Institute of Neurological Disorders
and Stroke, NIH, 31 Center Drive, Room
8A03, Bethesda, MD 20892, (301) 496–9271,
Email: IPRCC PublicInquries@mail.nih.gov.
Please Note: The conference call will be
accessible to the public through a call-in
number and access code. Members of the
public who participate using the conference
call phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with the
conference call, please call Customer Service
at 866–900–1011.
Individuals who participate by using this
electronic service and who need special
assistance or other reasonable
accommodations should submit a request to
the Contact Person listed on this notice at
least 7 days prior to the meeting.
This meeting is being published less than
15 days prior to the meeting. This timing
allows the IPRCC to get feedback from the
IPRCC Working Group, who meets the
previous week, while still providing time for
the recommendations from the
teleconference to be implemented before the
October 22, 2012, meeting.
Information about the IPRCC is available
on the Web site: www.iprcc.nih.gov.
Dated: June 11, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy .
[FR Doc. 2012–14932 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
srobinson on DSK4SPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Mar<15>2010
16:39 Jun 18, 2012
Jkt 226001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Clinical Trial
Planning Grants in Type 1 Diabetes.
Date: July 12, 2012.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452,
(301) 594–7791,
goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK IBD Genetics
Consortium Research Centers U01
Application Review.
Date: July 19, 2012.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NURSA Hub.
Date: August 2, 2012.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Barbara A Woynarowska,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 754, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452,
(301) 402–7172,
woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–14929 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Support for
Conference and Scientific meetings (R13)
2012–10.
Date: July 20, 2012.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6707
Democracy Blvd., Rm. 851, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Robert Nettey, M.D., Chief,
Scientific Review Officer, National Institutes
of Health, National Institute on Minority
Health and Health Disparities, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 496–3996, netteyr@mail.nih.gov.
Dated: June 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–14928 Filed 6–18–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 77, Number 118 (Tuesday, June 19, 2012)]
[Notices]
[Pages 36563-36564]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14932]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a conference call of
the Interagency Pain Research Coordinating Committee (IPRCC).
The IPRCC full Committee will be having a conference call on
Thursday, June 28, 2012. This teleconference will be focused
predominantly on a discussion of the proposed list of pain research
topics that will be used for the portfolio analysis of Federally-funded
pain research. This conference call will be accessible to the public
through a call-in number and access code.
Name of Committee: Interagency Pain Research Coordinating
Committee (IPRCC).
[[Page 36564]]
Type of meeting: Open Meeting.
Date: June 28, 2012.
Time: 1:00 p.m. to 2:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: To discuss the proposed list of pain research topics
that will be used for the portfolio analysis of Federally-funded
pain research.
Place: No in-person meeting; conference call only.
Conference Call: Dial: 800-369-2109, Access Code: 5033271.
Cost: The conference call is free and open to the public.
Contact Person: Dr. Paul Scott, Director, Office of Science
Policy and Planning, National Institute of Neurological Disorders
and Stroke, NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892,
(301) 496-9271, Email: IPRCC PublicInquries@mail.nih.gov.
Please Note: The conference call will be accessible to the
public through a call-in number and access code. Members of the
public who participate using the conference call phone number will
be able to listen to the meeting but will not be heard. If you
experience any technical problems with the conference call, please
call Customer Service at 866-900-1011.
Individuals who participate by using this electronic service and
who need special assistance or other reasonable accommodations
should submit a request to the Contact Person listed on this notice
at least 7 days prior to the meeting.
This meeting is being published less than 15 days prior to the
meeting. This timing allows the IPRCC to get feedback from the IPRCC
Working Group, who meets the previous week, while still providing
time for the recommendations from the teleconference to be
implemented before the October 22, 2012, meeting.
Information about the IPRCC is available on the Web site:
www.iprcc.nih.gov.
Dated: June 11, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy .
[FR Doc. 2012-14932 Filed 6-18-12; 8:45 am]
BILLING CODE 4140-01-P
